OPC-6535 Tablets (drug)

DRUG2 trials

Sponsors

Otsuka Pharmaceutical Development & Commercialization, Inc.

Conditions

Ulcerative Colitis

Phase 3

FACTS I: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis

CompletedNCT00064441

Otsuka Pharmaceutical Development & Commercialization, Inc.Ulcerative Colitis

Start: 2003-05-31End: 2006-05-31Target: 375Updated: 2012-05-10

FACTS II: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis

CompletedNCT00064454

Otsuka Pharmaceutical Development & Commercialization, Inc.Ulcerative Colitis

Start: 2003-05-31End: 2006-07-31Target: 375Updated: 2012-05-10